Glucocorticoids in the treatment of rheumatic diseases: An update on the mechanisms of action

医学 动作(物理) 重症监护医学 物理 量子力学
作者
Frank Buttgereit,Rainer H. Straub,Martin Wehling,Gerd‐Rüdiger Burmester
出处
期刊:Arthritis & Rheumatism [Wiley]
卷期号:50 (11): 3408-3417 被引量:367
标识
DOI:10.1002/art.20583
摘要

Six years after we published our first article on the mechanisms of action of glucocorticoids (GCs) (1), there is already a need for an update. GCs are superior to many drugs in terms of the number of patients treated, the variety of potential uses, and the experience with treatment in humans. They still represent the most important and most frequently used class of antiinflammatory drugs, and their therapeutic use has risen continuously in recent years (2). About 10 million new prescriptions for oral GCs are written each year in the US alone (2). They are the silent companions of rheumatologists, and it is impossible to imagine therapy— especially oral therapy, but intravenous and intraarticular as well—without them. From community survey data, the frequency of oral GC use has been estimated to be 0.5% of the general population and 1.75% of women over the age of 55 years (3,4). Between 56% and 68% of patients with rheumatoid arthritis are treated more or less continuously with GCs (5–8). GCs are relatively inexpensive drugs, but it is the sheer volume used that is significant overall; the total market size is believed to be about 10 billion US dollars per year (2). Our understanding of the actions of GCs has also greatly increased in the last few years. In this review, we report on recent insights relating to 1) signaling, transcription processes, and gene expression as induced, inhibited, and/or modified by the interaction of GCs with their cytosolic receptors, 2) relationships between dosages and plasma levels, 3) membrane-bound GC receptors (GCRs), and 4) new (glucocorticoid) drugs on the horizon. These data support the modular concept we proposed in 1998 (1), and so this update follows the same structure.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
miaomiao1132完成签到 ,获得积分20
1秒前
碧烟完成签到 ,获得积分10
1秒前
达达的马蹄完成签到,获得积分10
1秒前
大模型的应助被尘南浔采纳,获得10
1秒前
2秒前
Xi完成签到,获得积分10
3秒前
3秒前
悦耳的城发布了新的文献求助10
3秒前
123关闭了123的文献求助
3秒前
廿二完成签到 ,获得积分10
4秒前
桥波完成签到,获得积分20
4秒前
脑洞疼的应助被shark采纳,获得10
4秒前
小雷顺顺顺完成签到,获得积分10
4秒前
5秒前
5秒前
6秒前
周大大完成签到 ,获得积分10
6秒前
XX发布了新的文献求助10
6秒前
研友_VZG7GZ的应助被April采纳,获得10
6秒前
6秒前
111完成签到,获得积分10
8秒前
CipherSage的应助被菠菜吖采纳,获得10
8秒前
乐乐的应助被冷静白山采纳,获得10
8秒前
8秒前
好hshs发布了新的文献求助10
8秒前
9秒前
9秒前
小沈发布了新的文献求助10
10秒前
10秒前
YOUYOURS发布了新的文献求助50
11秒前
11秒前
12秒前
12秒前
wuyi完成签到,获得积分10
13秒前
13秒前
13秒前
灵巧绿海发布了新的文献求助10
14秒前
犹豫安波发布了新的文献求助10
14秒前
zz发布了新的文献求助10
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193925
求助须知:如何正确求助?哪些是违规求助? 9579945
关于积分的说明 21868504
捐赠科研通 7793568
什么是DOI,文献DOI怎么找? 3437462
关于科研通互助平台的介绍 2560923
邀请新用户注册赠送积分活动 2484250